SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Healthcare > Nxstage Medical, Inc. (NXTM)

7:27AM Nxstage Medical beats by $0.01, beats on

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 423
Posts 22,969
Boards Moderated 5
Alias Born 09/11/06
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/19/2017 3:28:42 PM
NxStage Announces Winners of Third Annual Nurse Hero Award "PR Newswire (US)" - 10/18/2017 9:10:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/6/2017 5:07:26 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/4/2017 5:08:27 PM
Jeffrey H. Burbank Joins CryoLife Board of Directors "PR Newswire (US)" - 10/2/2017 8:04:00 AM
Proxy Statement - Merger or Acquistion (definitive) (defm14a) "Edgar (US Regulatory)" - 9/22/2017 4:04:29 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/21/2017 7:15:20 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/21/2017 7:08:06 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/13/2017 5:08:29 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 9/11/2017 11:27:35 AM
Monteverde & Associates PC Announces An Investigation Of Nxstage Medical, Inc. - NXTM "PR Newswire (US)" - 9/10/2017 8:45:00 AM
Proxy Statement - Merger or Acquistion (preliminary) (prem14a) "Edgar (US Regulatory)" - 9/6/2017 5:00:55 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 4:08:53 PM
NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage® System One™ "PR Newswire (US)" - 8/28/2017 8:00:00 AM
NxStage System One Now in Nine of Top Ten U.S. Nephrology Hospitals "PR Newswire (US)" - 8/24/2017 11:39:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/23/2017 4:15:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/15/2017 4:36:55 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 8/11/2017 4:41:29 PM
NxStage Kidney Care and Dialyze Direct to Provide On-Site Dialysis to Skilled Nursing Facility Patients in Ohio "PR Newswire (US)" - 8/11/2017 9:41:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/10/2017 4:16:04 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/8/2017 6:36:26 PM
Rowley Law PLLC is Investigating NxStage Medical, Inc. and its Board of Directors for Potential Breaches of Fiduciary Duty "PR Newswire (US)" - 8/8/2017 5:30:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/8/2017 5:17:26 PM
WeissLaw LLP: NxStage Medical, Inc. Acquisition May Not Be in the Best Interests of NXTM Shareholders "PR Newswire (US)" - 8/8/2017 2:38:00 PM
Fresenius Adds To Push in U.S. With Health Deal Fresnius Unit To Pay $2 Billion For Dialysis Firm Fresenius Unit To Pay $2 Bi... "Dow Jones News" - 8/8/2017 3:02:00 AM
surf1944   Wednesday, 02/29/12 12:11:47 PM
Re: surf1944 post# 6
Post # of 17 
7:27AM Nxstage Medical beats by $0.01, beats on revs; guides Q1 EPS below consensus, revs in-line; guides FY12 EPS, revs below consensus (NXTM) 20.36 : Reports Q4 (Dec) loss of $0.08 per share, $0.01 better than the Capital IQ Consensus Estimate of ($0.09); revenues rose 14.5% year/year to $57 mln vs the $56.25 mln consensus. Co issues guidance for Q1, sees EPS of ($0.09)-(0.11) vs. ($0.06) Capital IQ Consensus Estimate; sees Q1 revs of $56-57 mln vs. $56.94 mln Capital IQ Consensus Estimate. Co issues downside guidance for FY12, sees EPS of ($0.25)-(0.32) vs. ($0.13) Capital IQ Consensus Estimate; sees FY12 revs of $240-245 mln vs. $245.39 mln Capital IQ Consensus Estimate.


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist